Fai-Meng Sou, Chien-Ning Hsu, Yi-Chun Chiu, Cheng-Kun Wu, Lung-Sheng Lu, Chung-Mou Kuo, Shao-Ming Chiu, Seng-Kee Chuah, Yao-Hsu Yang, Chih-Ming Liang
BACKGROUND: Statins may reduce the risk of recurrent gallstone disease by decreasing bile cholesterol saturation and pathogenicity. However, limited studies have investigated this issue. This study aimed to assess whether statin doses and serum cholesterol levels were associated with a decreased risk of recurrent biliary stone diseases after the first event index, with a follow-up time of 15 years. METHODS: Based on the Chang Gung Research Database (CGRD) between January 1, 2001, and December 31, 2020, we enrolled 68,384 patients with the International Classification of Diseases, Ninth and Tenth Revision codes of choledocholithiasis...
April 7, 2024: Journal of the Formosan Medical Association